IDH1 and IDH2 mutations have been identified in acute myelogenous leukemia, lymphoma, glioblastoma, chondrosarcoma and other solid tumours (Yan et al., 2009; Ward et al., 2010; Cairns et al., 2012; Cancer Genome and Atlas Network, 2012). The gene discussed is IDH2; the disease is chondrosarcoma.